2012-09-17 06:11:00 - Recently published research from Global Markets Direct, "Epilepsy - Pipeline Review, H2 2012", is now available at Fast Market Research

Global Markets Direct's, 'Epilepsy - Pipeline Review, H2 2012', provides an overview of the Epilepsy therapeutic pipeline. This report provides information on the therapeutic development for Epilepsy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Epilepsy. 'Epilepsy - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Full Report Details at

- www.fastmr.com/prod/463848_epilepsy_pipeline_review_h2_2012.aspx


Scope

* A snapshot of the global therapeutic scenario for Epilepsy.
* A review of the Epilepsy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Epilepsy pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Epilepsy.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Epilepsy pipeline depth and focus of Epilepsy therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Epilepsy Therapeutic Products under Development, Key Players in Epilepsy Therapeutics, Epilepsy Pipeline Overview, Epilepsy Pipeline, Epilepsy Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Epilepsy Overview
Therapeutics Development
An Overview of Pipeline Products for Epilepsy
Epilepsy Therapeutics under Development by Companies
Epilepsy Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Epilepsy Therapeutics - Products under Development by Companies
Epilepsy Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Epilepsy Therapeutics Development
Kyowa Hakko Kirin Co., Ltd.
NsGene A/S
Dainippon Sumitomo Pharma Co., Ltd.
Neurocrine Biosciences, Inc.
Novartis AG
Eisai Co., Ltd.
H Lundbeck A/S
Meiji Holdings Co., Ltd.
Pfizer Inc.
UCB Group
Vertex Pharmaceuticals Incorporated
Aeolus Pharmaceuticals, Inc.
GW Pharmaceuticals plc
Icagen Inc
Anavex Life Sciences Corp.
Ligand Pharmaceuticals Incorporated
Bionomics Limited
Neuro-Hitech, Inc.
NeuroSearch A/S
Catalyst Pharmaceutical Partners, Inc.
NPS Pharmaceuticals, Inc.
CombinatoRx, Incorporated
Proximagen Neuroscience plc.
NeuroVive Pharmaceutical AB
Paloma Pharmaceuticals, Inc.
Bio-Link
D-Pharm Ltd.
Upsher-Smith Laboratories, Inc.
Snowdon Inc.
BioMAS Ltd.
CREABILIS Therapeutics S.r.l.
Ache Laboratorios Farmaceuticos S/A
MedGenesis Therapeutix Inc.
Chlorion Pharma, Inc.
Supernus Pharmaceuticals, Inc.
Celentyx Ltd.
Nobelpharma Co., Ltd.
Concert Pharmaceuticals, Inc.
Biovista Inc.
Marinus Pharmaceuticals, Inc.
Bial - Portela & Ca, S.A.
Sihuan Pharmaceutical Holdings Group Ltd.
Neurelis, Inc.
Vichem Chemie Research Ltd.
Epilepsy - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
ANAVEX-2-73 - Drug Profile
Vimpat - Drug Profile
Vimpat - Drug Profile
Brivaracetam - Drug Profile
Fycompa - Drug Profile
Fycompa - Drug Profile
Carbamazepine - Drug Profile
ICA-105665 - Drug Profile
AEDs - Drug Profile
NPSP-156 - Drug Profile
CSC 700 Series - Drug Profile
Stedesa - Drug Profile
CX1010 - Drug Profile
Keppra - Drug Profile
Vanquix - Drug Profile
Tonabersat - Drug Profile
Dynamin Modulators - Drug Profile
NHT1107 - Drug Profile
Cannabinoids For Epilepsy - Drug Profile
Topiramate - Drug Profile
ANAVEX-19-144 - Drug Profile
VX-765 - Drug Profile
GABA-A agonists - Drug Profile
CT637 - Drug Profile
NSD-721 - Drug Profile
CLP-290 - Drug Profile
YKP3089 - Drug Profile
Naluzotan - Drug Profile
CPP-115 - Drug Profile
NsG0501 - Drug Profile
Levetiracetam - Drug Profile
DP-VPA - Drug Profile
Topiramate - Drug Profile
Bumetanide - Drug Profile
Carvedilol-CR - Drug Profile
Biperiden - Drug Profile
AS101 - Drug Profile
BGG-492 - Drug Profile
Lorazepam - Drug Profile

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463848&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.